Literature DB >> 24626807

Prostaglandin E₂ receptor EP2 mediates Snail expression in hepatocellular carcinoma cells.

Shan-Yu Cheng1, Hai Zhang1, Min Zhang1, Shu-Kai Xia1, Xiao-Ming Bai1, Li Zhang1, Juan Ma1, Rong Rong1, Yi-Pin Wang1, Ming-Zhan Du1, Jie Wang1, Meng Chen1, Feng Shi1, Qin-Yi Yang1, Jing Leng1.   

Abstract

Prostaglandin E2 (PGE2) has been shown to influence cell invasion and metastasis in several types of cancer, including hepatocellular carcinoma (HCC). however, the molecular mechanisms underlying it remain to be further elucidated. Snail, as one of key inducers of epithelial-mesenchymal transition (EMT), plays pivotal roles in HCC invasion and metastasis. The present study was designed to evaluate the possible signaling pathways through which PGE2 regulates Snail protein expression in HCC cell lines. PGE2 markedly enhanced Huh-7 cell invasion and migration ability by upregulating the expression level of Snail protein, and EP2 receptor played an important role in this process. Src, EGFR, Akt and mTOR were all activated and involved in the regulation of snail protein expression. Our findings suggest that PGE2 could upregulate the expression level of Snail protein through the EP2/Src/EGFR/Akt/mTOR pathway in Huh-7 cells, which promotes HCC cell invasion and migration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24626807     DOI: 10.3892/or.2014.3074

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  14 in total

Review 1.  Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?

Authors:  G O'Callaghan; A Houston
Journal:  Br J Pharmacol       Date:  2015-10-26       Impact factor: 8.739

2.  Selective EP2 and Cox-2 inhibition suppresses cell migration by reversing epithelial-to-mesenchymal transition and Cox-2 overexpression and E-cadherin downregulation are implicated in neck metastasis of hypopharyngeal cancer.

Authors:  Yoshihiro Watanabe; Yorihisa Imanishi; Hiroyuki Ozawa; Koji Sakamoto; Ryoichi Fujii; Seiji Shigetomi; Noboru Habu; Kuninori Otsuka; Yoichiro Sato; Mariko Sekimizu; Fumihiro Ito; Yuichi Ikari; Shin Saito; Kaori Kameyama; Kaoru Ogawa
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

Review 3.  Targeting the eicosanoid pathway in hepatocellular carcinoma.

Authors:  Anshuli Razdan; Nathan M Main; Vincent Chiu; Nicholas A Shackel; Paul de Souza; Katherine Bryant; Kieran F Scott
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

4.  Germline Variants and Genetic Interactions of Several EMT Regulatory Genes Increase the Risk of HBV-Related Hepatocellular Carcinoma.

Authors:  Wen-Xuan Liu; Lei Yang; Hui-Min Yan; Li-Na Yan; Xiao-Lin Zhang; Ning Ma; Long-Mei Tang; Xia Gao; Dian-Wu Liu
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

5.  Expression of prostaglandin E2 prostanoid receptor EP2 and interleukin-1β in laryngeal carcinoma - preliminary study.

Authors:  Marcin Mochocki; Piotr Morawski; Renata Kopta; Ewa Brzezińska-Błaszczyk; Olga Stasikowska; Iwona Lewy-Trenda; Katarzyna Starska
Journal:  Contemp Oncol (Pozn)       Date:  2015-05-13

Review 6.  Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma.

Authors:  Wen-Ting Peng; Wu-Yi Sun; Xin-Ran Li; Jia-Chang Sun; Jia-Jia Du; Wei Wei
Journal:  Int J Mol Sci       Date:  2018-05-04       Impact factor: 5.923

7.  Eicosanoids and cancer.

Authors:  Renata Nascimento Gomes; Souza Felipe da Costa; Alison Colquhoun
Journal:  Clinics (Sao Paulo)       Date:  2018-08-20       Impact factor: 2.365

Review 8.  Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside.

Authors:  Gabriel Siracusano; Mariella Tagliamonte; Luigi Buonaguro; Lucia Lopalco
Journal:  Vaccines (Basel)       Date:  2020-01-24

9.  High expression of Snail and NF-κB predicts poor survival in Chinese hepatocellular carcinoma patients.

Authors:  Min Zhang; Xin Dong; Dengcai Zhang; Xiaojie Chen; Xinyu Zhu
Journal:  Oncotarget       Date:  2017-01-17

10.  FADS1 promotes the progression of laryngeal squamous cell carcinoma through activating AKT/mTOR signaling.

Authors:  Rui Zhao; Linli Tian; Bo Zhao; Yanan Sun; Jing Cao; Kexin Chen; Fengqing Li; Minghua Li; Desi Shang; Ming Liu
Journal:  Cell Death Dis       Date:  2020-04-24       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.